EUVIMEDExplore EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Catheter ablation of atrial fibrillation using FireMagic TrueForce ablation catheter: The TRUEFORCE trial

Rongfeng Zhang iD, Huimin Chu iD, Shaowen Liu iD, Bing Yang, Bing Han iD, Xianjie Xiao, Chengming Ma, Yuanjun Sun, Xiaomeng Yin, Yunlong Xia iD, Lianjun Gao, TRUEFORCE investigators.

Pacing and Clinical Electrophysiology · 2023

DOI: 10.1111/pace.14751 ↗

At a glance

Multizentrische Studie in Pacing and Clinical Electrophysiology, 2023. Written by Rongfeng Zhang and 11 co-authors. Institution: Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China. Major MEDLINE topics: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation. 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Background

The use of contact force (CF) sensing catheters has provided a revolutionary improvement in catheter ablation (CA) of atrial fibrillation (AF) in the past decade. However, the success rate of CA for AF remains limited, and some complications still occur.

Methods

The TRUEFORCE trial (Catheter Ablation of Atrial Fibrillation using FireMagic TrueForce Ablation Catheter) is a multicenter, prospective, single‐arm objective performance criteria study of AF patients who underwent their first CA procedure using FireMagic TrueForce ablation catheter.

Results

A total of 120 patients (118 with paroxysmal AF) were included in this study, and 112 patients included in the per‐protocol analysis. Pulmonary vein isolation (PVI) was achieved in 100% of the patients, with procedure and fluoroscopy time of 146.63 ± 40.51 min and 12.89 ± 5.59 min, respectively. Freedom from recurrent atrial arrhythmia after ablation was present 81.25% (95% confidence interval [CI]: 72.78%–88.00%) of patients. No severe adverse events (death, stroke/transient ischemic attack [TIA], esophageal fistula, myocardial infarction, thromboembolism, or pulmonary vein stenosis) were detected during the follow‐up. Four (4/115, 3.33%) adverse events were documented, including one abdominal discomfort, one femoral artery hematoma, one coughing up blood, and one postoperative palpitation and insomnia.

Conclusions

This study demonstrated the clinical feasibility of FireMagic force‐sensing ablation catheter in CA of AF, with a satisfactory short‐ and long‐term efficacy and safety.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationPulmonary VeinsCatheter AblationHumansProspective StudiesTreatment OutcomeCathetersRecurrence

Author keywords

atrial fibrillationcatheter ablationcontact force

Authors and institutions

  • Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Cardiology, Ningbo First Hospital, Ningbo, China.
  • Department of Cardiology, Shanghai General Hospital, Shanghai, China.
  • Department of Cardiology, Dongfang Hospital Affiliated to Tongji University, Shanghai, China.
  • Department of Cardiology, Xuzhou Central Hospital, Xuzhou, China.

ORCID profiles: Rongfeng Zhang, Huimin Chu, Shaowen Liu, Bing Han, Yunlong Xia

Cite

APA

Zhang, R., Chu, H., Liu, S., Yang, B., Han, B., Xiao, X., Ma, C., Sun, Y., Yin, X., Xia, Y., Gao, L., & TRUEFORCE investigators. (2023). Catheter ablation of atrial fibrillation using FireMagic TrueForce ablation catheter: The TRUEFORCE trial. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14751

Vancouver

Zhang R, Chu H, Liu S, Yang B, Han B, Xiao X, et al. Catheter ablation of atrial fibrillation using FireMagic TrueForce ablation catheter: The TRUEFORCE trial. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14751

BibTeX
@article{Zhang2023,
  author = {Zhang, Rongfeng and Chu, Huimin and Liu, Shaowen and Yang, Bing and Han, Bing and Xiao, Xianjie and Ma, Chengming and Sun, Yuanjun and Yin, Xiaomeng and Xia, Yunlong and Gao, Lianjun and TRUEFORCE investigators., TRUEFORCE investigators.},
  title = {Catheter ablation of atrial fibrillation using FireMagic TrueForce ablation catheter: The TRUEFORCE trial},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  doi = {10.1111/pace.14751}
}
Start for free →